Moberg Pharma AB
@mobergpharma.se
Moberg Pharma AB (publ) är ett svenskt läkemedelsbolag med fokus på kommersialisering av egenutvecklade läkemedel baserade på beprövade substanser. Bolagets läkemedel MOB-015 är en ny utvärtes behandling av nagelsvamp, med marknadsgodkännande i 13 EU länder. MOB-015 säljs i Sverige under varumärket...
Moberg Pharma AB's Company Logos
Moberg Pharma AB's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#2E659E
Azure
46, 101, 158
211, 55, 40
71, 36, 0, 38
#97B2CF
Polo Blue
151, 178, 207
211, 37, 70
27, 14, 0, 19
#111111
Cod Gray
17, 17, 17
0, 0, 7
0, 0, 0, 93
About Moberg Pharma AB
Moberg Pharma AB is a Swedish pharmaceutical company that specializes in the commercialization of self-developed, acquired, and licensed products on the global market. With its origins in the treatment of skin diseases, particularly focusing on nail fungus, Moberg Pharma offers innovative solutions to improve the health and well-being of individuals worldwide. One of the company's flagship products, MOB-015, has shown promising results in two phase 3 studies, demonstrating its unique antifungal properties.
As a result, MOB-015 is recommended for market approval in the EU, paving the way for effective treatment options for nail fungus. Employing a robust business model, Moberg Pharma reduces development risks and increases opportunities to quickly penetrate the market, distinguishing itself from traditional pharmaceutical development approaches. Discover more about Moberg Pharma's extensive pipeline and partnerships, which are driving the development of new medicines for a global market.
Stay up to date with the latest news and announcements by subscribing to their press releases and reports. Contact Moberg Pharma AB for further information and inquiries about their products and services
Company type
Public Company
Year founded
2006
Company size
11-50 employees
Related Brands
Tags
Specialty pharmaceuticals
Dermatology medicines
Topical antifungal treatment
Nail fungus (onychomycosis)
EU drug approvals
